- Home
- GAMB vs LFCR Comparison
GAMB vs LFCR Comparison
Compare GAMB & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAMB
- LFCR
- Stock Information
- Founded
- GAMB 2006
- LFCR 1986
- Country
- GAMB Jersey
- LFCR United States
- Employees
- GAMB N/A
- LFCR N/A
- Industry
- GAMB Services-Misc. Amusement & Recreation
- LFCR Biotechnology: Pharmaceutical Preparations
- Sector
- GAMB Consumer Discretionary
- LFCR Health Care
- Exchange
- GAMB Nasdaq
- LFCR Nasdaq
- Market Cap
- GAMB 273.9M
- LFCR 255.1M
- IPO Year
- GAMB 2021
- LFCR N/A
- Fundamental
- Price
- GAMB $7.13
- LFCR $7.19
- Analyst Decision
- GAMB Strong Buy
- LFCR Buy
- Analyst Count
- GAMB 8
- LFCR 4
- Target Price
- GAMB $15.13
- LFCR $8.00
- AVG Volume (30 Days)
- GAMB 737.9K
- LFCR 167.9K
- Earning Date
- GAMB 11-13-2025
- LFCR 11-06-2025
- Dividend Yield
- GAMB N/A
- LFCR N/A
- EPS Growth
- GAMB N/A
- LFCR N/A
- EPS
- GAMB 0.40
- LFCR N/A
- Revenue
- GAMB $147,655,000.00
- LFCR $128,867,000.00
- Revenue This Year
- GAMB $38.41
- LFCR $4.72
- Revenue Next Year
- GAMB $11.58
- LFCR $10.97
- P/E Ratio
- GAMB $17.99
- LFCR N/A
- Revenue Growth
- GAMB 27.57
- LFCR 0.47
- 52 Week Low
- GAMB $7.03
- LFCR $4.76
- 52 Week High
- GAMB $17.14
- LFCR $8.85
- Technical
- Relative Strength Index (RSI)
- GAMB 32.14
- LFCR 57.46
- Support Level
- GAMB $7.55
- LFCR $6.61
- Resistance Level
- GAMB $7.84
- LFCR $7.37
- Average True Range (ATR)
- GAMB 0.26
- LFCR 0.25
- MACD
- GAMB -0.02
- LFCR 0.08
- Stochastic Oscillator
- GAMB 10.87
- LFCR 82.69
About GAMB Gambling.com Group Limited
Gambling.com Group Ltd is a multi-award-winning performance marketing company and a provider of digital marketing services in the online gambling industry. Its principal focus is on online casinos online sports betting and the fantasy sports industry. It generates revenue by referring online gamblers to online gambling operators.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.